Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
30.49
41.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Total Equity
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Equity
¥12.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
22%
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Equity
¥1.9B
|
CAGR 3-Years
61%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Equity
¥38.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Total Equity
¥3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Total Equity
¥15.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
18%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Equity
¥18.9B
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Glance View
Jiangsu Yuyue Medical Equipment & Supply Co Ltd embodies the dynamic spirit of China's burgeoning healthcare sector. Founded in the heart of China's manufacturing hub, Jiangsu province, this company has steadily carved a niche for itself in the realm of medical equipment and supplies. With an eye for innovation and a sharp focus on quality, Yuyue specializes in the production of respiratory care devices, blood pressure monitors, and other medical diagnostics tools that are essential in both clinical settings and at-home healthcare. The company’s dedication to integrating advanced technology with user-friendly designs has not only propelled its domestic growth but also increased its footprint in international markets. By meticulously ensuring their products meet stringent regulatory standards, Yuyue competently aligns itself with the healthcare industry's rigorous demands. The financial lifeblood of Jiangsu Yuyue lies in its robust sales and distribution networks, which are critical in a sector as diversified and regulation-intensive as medical equipment. Through an extensive distribution network, including direct sales, strategic partnerships, and well-developed online platforms, the company effectively reaches both institutional clients and individual consumers. Additionally, the company leverages economies of scale and in-house expertise to maintain competitive pricing, helping it capture substantial market share. As healthcare needs continue to evolve globally, Yuyue's commitment to research and development positions it to not only meet current demands but also anticipate future trends, ensuring continuous revenue growth and reinforcing its status as a prominent player in the medical equipment industry.
See Also
What is Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Total Equity?
Total Equity
12.1B
CNY
Based on the financial report for Sep 30, 2024, Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Total Equity amounts to 12.1B CNY.
What is Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
22%
Over the last year, the Total Equity growth was 5%. The average annual Total Equity growth rates for Jiangsu Yuyue Medical Equipment & Supply Co Ltd have been 14% over the past three years , 15% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet